Who Are We?

Zyleris provides contract research services for topical pharmaceutical development.  Established in 2010, Zyleris has been at forefront in developing technologies and providing services for topical formulation development.  We aim to become your trusted service provider.

What Do We Offer Specifically?

A full suite of topical formulation development, screening, and optimization services, including tissue permeation screening (IVPT), in vitro release test (IVRT), topical formulation development and optimization, and formulation reverse-engineering/generic formulation development.

How Are We Different?

First technology developed at Zyleris is a first-in-class, proprietary high-throughput Franz Cell technology platform.  This technology is fully validated against the industry standard Franz Cell technology.  It revolutionizes topical formulation development and evaluation.

Zyleris believes that innovation is a key to stay competitive and deliver values to our clients.  We devote significant amount of resources to improve existing technologies and develop new technologies.  These proprietary and patent-protected technologies have extensively utilized in services we provide.

What Does This Mean To You?

Fastercheaper, and better way to develop superior topical formulations.